Stockreport

Goldman Sachs Raises Bristol-Myers (BMY) Target, Keeps Neutral Rating [Yahoo! Finance]

Goldman Sachs Group, Inc. (The)  (GS) 
Last goldman sachs group, inc. (the) earnings: 4/15 07:30 am Check Earnings Report
US:NYSE Investor Relations: goldmansachs.com/investor-relations
PDF On December 15, Goldman Sachs raised the firm's price target on Bristol-Myers Squibb Company (NYSE:BMY) to $57 from $51 and kept a Neutral rating on the shares. Brist [Read more]